Showing results (1-10 of 418) with videos related to
Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?Francesco Sabbatino, Soldano FerroneExpert Opinion on Biological Therapy|February 8, 2022
Immune checkpoint inhibitors for the treatment of melanomaFrancesco Sabbatino, Luigi Liguori, Stefano Pepe, et al.Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanomaYangyang Wang, Francesco Sabbatino, Xinhui Wang, et al.Clinical Transplants|August 7, 2014
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cellsFrancesco Sabbatino, Joseph H Schwab, Soldano Ferrone, et al.Expert Opinion on Emerging Drugs|October 1, 2013
Emerging BRAF inhibitors for melanomaFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.Seminars in Oncology|December 3, 2014
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumorsFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.Journal for Immunotherapy of Cancer|November 22, 2018
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literatureFrancesco Sabbatino, Antonio Marra, Luigi Liguori, et al.Oncotargets and Therapy|February 27, 2014
Ipilimumab in the treatment of metastatic melanoma: management of adverse eventsGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Perri, et al.Anti-Cancer Agents in Medicinal Chemistry|December 20, 2017
Translational Research in Cutaneous Melanoma: New Therapeutic PerspectivesAntonio Marra, Cristina R Ferrone, Celeste Fusciello, et al.Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Multidisciplinary approach to patient with malignant melanomaGiuseppina Della Vittoria Scarpati, Celeste Fusciello, Francesco Sabbatino, et al.Pageof 42